The number of people with susceptibility test result for rifampicin in Kyrgyzstan
Kyrgyzstan: The number of people with susceptibility test result for rifampicin was 1,932 in 2021. ▼ Falling
Latest (2021)
1,932
Change on year
up 11.0%
World rank
49th
of 155 countries
All-time high
2,375
in 2019
All-time low
1,741
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Kyrgyzstan, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Kyrgyzstan recorded 1,932 for the number of people with susceptibility test result for rifampicin in 2021.
Compared with earlier readings it is up 11.0% on the previous year and down 15.3% over five years.
That places Kyrgyzstan 49th out of 155 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Kyrgyzstan, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 2,282 | — |
| 2018 | 2,291 | +0.4% |
| 2019 | 2,375 | +3.7% |
| 2020 | 1,741 | -26.7% |
| 2021 | 1,932 | +11.0% |
Kyrgyzstan compared with similar countries
- Kyrgyzstan's 1,932 is below the median for lower middle income countries, which is 2,804, 69% of the median. (32 countries reporting)
- Kyrgyzstan's 1,932 is above the median for Europe & Central Asia, which is 229.5, 8.4× the median. (44 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 2,316 | 2,282 | 2,375 | 3 |
| 2020s | 1,836 | 1,741 | 1,932 | 2 |
Countries ranked near Kyrgyzstan
More health data for Kyrgyzstan
- Un projection of annual infant deaths, annual growth rate -1.77 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6971 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 938.9 deaths per 1,000 people (2090)
- Number of infants who die before age 1 278 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2023)
- Population ages 00-04, female, annual growth rate -1.95 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0501 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.01 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Kyrgyzstan?
- The number of people with susceptibility test result for rifampicin in Kyrgyzstan was 1,932 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Kyrgyzstan?
- The highest recorded value was 2,375 in 2019.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Kyrgyzstan?
- The lowest recorded value was 1,741 in 2020.
- How does Kyrgyzstan rank for the number of people with susceptibility test result for rifampicin?
- Kyrgyzstan ranks 49th out of 155 countries with data for 2021.
- Where does this Kyrgyzstan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).